Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 1441 AL 1455

Daytime symptoms in restless legs syndrome - an underestimated problem?

Baier PC.

Sleep Med. 2012 Feb;13(2):121-2. doi: 10.1016/j.sleep.2011.11.001. Epub 2011 Dec 15.

Restless legs syndrome: relationship between prevalence and latitude

Koo BB.

Sleep Breath. 2012 Dec;16(4):1237-45. doi: 10.1007/s11325-011-0640-8. Epub 2011 Dec 31.

Restless legs syndrome

Miletić V, Relja M.

Coll Antropol. 2011 Dec;35(4):1339-47.

Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study)

Moreno-López C, Santamaría J, Salamero M, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Overeem S, Bloem B, Aarden W, Canesi M, Antonini A, Duerr S, Wenning GK, Poewe W, Rubino A, Meco G, Schneider SA, Bhatia KP, Djaldetti R, Coelho M, Sampaio C, Cochen V, Hellriegel H, Deuschl G, Colosimo C, Marsili L, Gasser T, Tolosa E.

Arch Neurol. 2011 Feb;68(2):223-30. doi: 10.1001/archneurol.2010.359.

Opioids protect against substantia nigra cell degeneration under conditions of iron deprivation: a mechanism of possible relevance to the Restless Legs Syndrome (RLS) and Parkinson's disease

Sun YM, Hoang T, Neubauer JA, Walters AS.

J Neurol Sci. 2011 May 15;304(1-2):93-101. doi: 10.1016/j.jns.2011.02.003. Epub 2011 Mar 3.

Ongoing challenges to finding people with Parkinson's disease for epidemiological studies: a comparison of population-level case ascertainment methods

Harris MA, Koehoorn M, Teschke K.

Parkinsonism Relat Disord. 2011 Jul;17(6):464-9. doi: 10.1016/j.parkreldis.2011.04.007. Epub 2011 May 4.

When Parkinson's disease patients go to sleep: specific sleep disturbances related to Parkinson's disease

Schulte EC, Winkelmann J.

J Neurol. 2011 May;258(Suppl 2):S328-35. doi: 10.1007/s00415-011-5933-0.

Deep brain stimulation: current and future clinical applications

Lyons MK.

Mayo Clin Proc. 2011 Jul;86(7):662-72. doi: 10.4065/mcp.2011.0045. Epub 2011 Jun 6.

[Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome]

Bayard S, Cochen De Cock V, Dauvillers Y.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):227-35. doi: 10.1684/pnv.2011.0275.

Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas

Martinkova J, Trejbalova L, Sasikova M, Benetin J, Valkovic P.

Clin Neuropharmacol. 2011 Sep-Oct;34(5):179-81. doi: 10.1097/WNF.0b013e3182281b2f.

[Pathological gambling induced by dopamine agonists]

Gahr M, Connemann BJ, Schönfeldt-Lecuona CJ.

Fortschr Neurol Psychiatr. 2011 Aug;79(8):470-4. doi: 10.1055/s-0031-1281580. Epub 2011 Aug 1.

Pharmacokinetic evaluation of pramipexole

Antonini A, Calandrella D.

Expert Opin Drug Metab Toxicol. 2011 Oct;7(10):1307-14. doi: 10.1517/17425255.2011.614232. Epub 2011 Sep 6.

Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment

Yeh P, Walters AS, Tsuang JW.

Sleep Breath. 2012 Dec;16(4):987-1007. doi: 10.1007/s11325-011-0606-x. Epub 2011 Oct 26.

Sleep disorders in Parkinson disease

Iranzo de Riquer A, Bergareche A, Campos V.

Neurologist. 2011 Nov;17(6 Suppl 1):S38-42. doi: 10.1097/NRL.0b013e31823966f8.

Prevalence of neuroleptic-induced restless legs syndrome in patients taking neuroleptic drugs

Jagota P, Asawavichienjinda T, Bhidayasiri R.

J Neurol Sci. 2012 Mar 15;314(1-2):158-60. doi: 10.1016/j.jns.2011.10.032. Epub 2011 Nov 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias